Birdwatch Note
2024-10-02 19:49:21 UTC - NOT_MISLEADING
NNN. Der Post gibt eine Expertenmeinung wieder. Der Begriff „Turbo-Krebs“ wurde als umgangssprachliche Bezeichnung in Anführungszeichen gesetzt. Es gibt zahlreiche Fallberichte über Krebserkrankungen im Zusammenhang mit COVID-Impfungen. Diskussion in Kommentaren. https://pubmed.ncbi.nlm.nih.gov/36676781/ https://europepmc.org/article/pmc/pmc9114986/ https://pubmed.ncbi.nlm.nih.gov/35966352/ https://ncbi.nlm.nih.gov/pmc/articles/PMC9377515/ https://ncbi.nlm.nih.gov/pmc/articles/PMC8656165/ https://www.mdpi.com/1648-9144/58/7/874 https://www.excli.de/index.php/excli/article/view/6145 https://www.mdpi.com/1648-9144/59/3/627
Written by 2ECC7E1FDCB58AB8F7A92BC90B832DE0836934E304C5518ED8F2AB97A6A91439
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1841526030462333042
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1841566159558070297
- noteId - 1841566159558070297
- participantId -
- noteAuthorParticipantId - 2ECC7E1FDCB58AB8F7A92BC90B832DE0836934E304C5518ED8F2AB97A6A91439 Participant Details
- createdAtMillis - 1727898561738
- tweetId - 1841526030462333042
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 1
- trustworthySources - 1
- summary
- NNN. Der Post gibt eine Expertenmeinung wieder. Der Begriff „Turbo-Krebs“ wurde als umgangssprachliche Bezeichnung in Anführungszeichen gesetzt. Es gibt zahlreiche Fallberichte über Krebserkrankungen im Zusammenhang mit COVID-Impfungen. Diskussion in Kommentaren. https://pubmed.ncbi.nlm.nih.gov/36676781/ https://europepmc.org/article/pmc/pmc9114986/ https://pubmed.ncbi.nlm.nih.gov/35966352/ https://ncbi.nlm.nih.gov/pmc/articles/PMC9377515/ https://ncbi.nlm.nih.gov/pmc/articles/PMC8656165/ https://www.mdpi.com/1648-9144/58/7/874 https://www.excli.de/index.php/excli/article/view/6145 https://www.mdpi.com/1648-9144/59/3/627
Note Ratings
rated at | rated by | |
2024-10-02 18:01:05 -0500 | Rating Details | |
2024-10-02 16:53:32 -0500 | Rating Details | |
2024-10-02 16:34:39 -0500 | Rating Details | |
2024-10-02 16:11:55 -0500 | Rating Details | |
2024-10-02 15:53:28 -0500 | Rating Details | |
2024-10-02 15:53:18 -0500 | Rating Details | |
2024-10-02 15:45:07 -0500 | Rating Details | |
2024-10-02 15:19:24 -0500 | Rating Details | |
2024-10-02 15:06:19 -0500 | Rating Details | |
2024-10-04 17:52:43 -0500 | Rating Details | |
2024-10-04 17:50:43 -0500 | Rating Details | |
2024-10-04 17:20:32 -0500 | Rating Details | |
2024-10-04 14:36:48 -0500 | Rating Details | |
2024-10-04 14:18:30 -0500 | Rating Details | |
2024-10-04 14:00:07 -0500 | Rating Details | |
2024-10-04 13:24:32 -0500 | Rating Details | |
2024-10-04 11:30:28 -0500 | Rating Details | |
2024-10-04 10:38:37 -0500 | Rating Details | |
2024-10-04 08:39:08 -0500 | Rating Details | |
2024-10-04 08:09:45 -0500 | Rating Details | |
2024-10-04 08:00:16 -0500 | Rating Details | |
2024-10-04 07:43:19 -0500 | Rating Details | |
2024-10-04 06:25:50 -0500 | Rating Details | |
2024-10-04 06:09:44 -0500 | Rating Details | |
2024-10-04 05:57:04 -0500 | Rating Details | |
2024-10-04 05:42:42 -0500 | Rating Details | |
2024-10-04 05:36:02 -0500 | Rating Details | |
2024-10-04 05:30:42 -0500 | Rating Details | |
2024-10-04 05:04:57 -0500 | Rating Details | |
2024-10-04 04:31:36 -0500 | Rating Details | |
2024-10-04 04:29:47 -0500 | Rating Details | |
2024-10-04 04:07:36 -0500 | Rating Details | |
2024-10-04 04:01:00 -0500 | Rating Details | |
2024-10-04 03:59:28 -0500 | Rating Details | |
2024-10-04 03:52:04 -0500 | Rating Details | |
2024-10-04 03:33:03 -0500 | Rating Details | |
2024-10-04 03:27:48 -0500 | Rating Details | |
2024-10-04 03:12:40 -0500 | Rating Details | |
2024-10-04 03:05:15 -0500 | Rating Details | |
2024-10-04 03:04:26 -0500 | Rating Details | |
2024-10-04 02:22:25 -0500 | Rating Details | |
2024-10-04 02:01:49 -0500 | Rating Details | |
2024-10-04 01:51:13 -0500 | Rating Details | |
2024-10-04 01:13:01 -0500 | Rating Details | |
2024-10-04 01:05:56 -0500 | Rating Details | |
2024-10-04 01:00:31 -0500 | Rating Details | |
2024-10-04 00:27:19 -0500 | Rating Details | |
2024-10-03 17:08:32 -0500 | Rating Details | |
2024-10-03 12:55:22 -0500 | Rating Details | |
2024-10-03 12:33:05 -0500 | Rating Details | |
2024-10-03 11:47:22 -0500 | Rating Details | |
2024-10-03 11:39:47 -0500 | Rating Details | |
2024-10-03 11:31:39 -0500 | Rating Details | |
2024-10-03 11:24:51 -0500 | Rating Details | |
2024-10-03 10:48:45 -0500 | Rating Details | |
2024-10-03 10:15:32 -0500 | Rating Details | |
2024-10-03 09:58:46 -0500 | Rating Details | |
2024-10-03 09:23:40 -0500 | Rating Details | |
2024-10-03 06:42:46 -0500 | Rating Details | |
2024-10-03 05:10:50 -0500 | Rating Details | |
2024-10-03 04:41:26 -0500 | Rating Details | |
2024-10-03 03:56:44 -0500 | Rating Details | |
2024-10-03 03:55:49 -0500 | Rating Details | |
2024-10-03 03:25:09 -0500 | Rating Details | |
2024-10-03 02:10:53 -0500 | Rating Details | |
2024-10-03 02:10:04 -0500 | Rating Details | |
2024-10-03 02:06:36 -0500 | Rating Details | |
2024-10-03 00:07:52 -0500 | Rating Details | |
2024-10-03 00:05:55 -0500 | Rating Details | |
2024-10-02 22:48:27 -0500 | Rating Details | |
2024-10-02 22:03:21 -0500 | Rating Details | |
2024-10-02 21:56:02 -0500 | Rating Details | |
2024-10-02 21:34:03 -0500 | Rating Details | |
2024-10-02 19:50:09 -0500 | Rating Details | |
2024-10-02 18:15:03 -0500 | Rating Details | |
2024-10-02 15:10:28 -0500 | Rating Details | |
2024-10-05 11:37:03 -0500 | Rating Details | |
2024-10-05 01:16:57 -0500 | Rating Details | |
2024-10-04 12:35:22 -0500 | Rating Details | |
2024-10-04 12:12:22 -0500 | Rating Details | |
2024-10-04 05:01:05 -0500 | Rating Details | |
2024-10-04 03:18:52 -0500 | Rating Details | |
2024-10-04 02:03:34 -0500 | Rating Details | |
2024-10-04 01:27:26 -0500 | Rating Details | |
2024-10-03 21:57:57 -0500 | Rating Details | |
2024-10-03 18:10:55 -0500 | Rating Details | |
2024-10-03 06:27:53 -0500 | Rating Details | |
2024-10-03 04:15:25 -0500 | Rating Details | |
2024-10-03 01:33:32 -0500 | Rating Details | |
2024-10-03 00:16:33 -0500 | Rating Details | |
2024-10-03 00:12:38 -0500 | Rating Details | |
2024-10-02 22:07:54 -0500 | Rating Details | |
2024-10-02 21:46:59 -0500 | Rating Details | |
2024-10-05 16:18:31 -0500 | Rating Details | |
2024-10-05 09:28:19 -0500 | Rating Details | |
2024-10-04 18:45:27 -0500 | Rating Details | |
2024-10-04 12:47:25 -0500 | Rating Details | |
2024-10-04 09:25:38 -0500 | Rating Details | |
2024-10-04 06:43:02 -0500 | Rating Details | |
2024-10-04 02:09:01 -0500 | Rating Details | |
2024-10-04 01:58:58 -0500 | Rating Details | |
2024-10-04 01:39:51 -0500 | Rating Details | |
2024-10-04 01:36:17 -0500 | Rating Details | |
2024-10-03 21:24:45 -0500 | Rating Details | |
2024-10-03 14:22:49 -0500 | Rating Details | |
2024-10-03 00:25:11 -0500 | Rating Details | |
2024-10-03 00:01:05 -0500 | Rating Details | |
2024-10-02 17:45:05 -0500 | Rating Details | |
2024-10-02 16:35:11 -0500 | Rating Details | |
2024-10-02 15:26:42 -0500 | Rating Details | |
2024-10-02 15:25:52 -0500 | Rating Details | |
2024-10-17 05:49:55 -0500 | Rating Details | |
2024-10-09 03:48:42 -0500 | Rating Details | |
2024-10-05 17:52:56 -0500 | Rating Details | |
2024-10-04 07:00:51 -0500 | Rating Details | |
2024-10-03 16:08:31 -0500 | Rating Details |